“…The structural diversity and biological activity of naturally occurring pyranonaphthoquinone γ‐lactones have piqued the interest of synthetic chemists and pharmacologists , . Some of that work leaned on the SAD strategy reviewed here: a route to 202 , conceived as an eastern building block of synthetic granaticin A ( 203 , Scheme ), syntheses, of unnatural but pharmacologically active model compounds 206a – e (Scheme ), syntheses of the natural products (+)–kalafungin ( 212 ), the antipodal (–)‐nanaomycin ( ent ‐ 212 ), and (+)‐frenolicin B ( 213 , all Scheme ), and totally synthetic accesses to the natural products arizonin C1 ( 222 , Scheme ) and griseusins A ( 233 ) and C ( 232 , both Scheme ). Each of these efforts involved the following steps in the indicated order: (1) preparation of a γ‐arylated β,γ‐unsaturated ester, (2) SAD (69–87 % yield, <95–99.5 % ee ) to give a γ‐lactone, and (3) dihydropyran formation through an “oxa‐Pictet–Spengler cyclization”.…”